Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kintara Therapeutics (KTRA)
NASDAQ:KTRA
RESEARCH TOOLSreports
Holding KTRA?
Track your performance easily
KTRA Stock Chart & Stats
Day’s Range$7.17 - $8.25
52-Week Range― - ―
Previous Close$8.05
Volume3.70M
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Nov 11, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding55,660,578
10 Day Avg. Volume2,424,710
30 Day Avg. Volume4,062,924
Standard Deviation0.32
R-Squared0.02
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)3.59
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Kintara Therapeutics News
PremiumCompany Announcements
Kintara Therapeutics Announces Stock Split Amid Merger
PremiumCompany Announcements
Kintara Therapeutics Updates on Merger and CVR Issuance
PremiumCompany Announcements
Kintara Therapeutics Set for Strategic Merger and CVR IssuanceOwnership Overview
―
Insiders
0.10% Mutual Funds
0.21% Other Institutional Investors
99.67% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
KTRA FAQ
What was Kintara Therapeutics’s price range in the past 12 months?
Currently, no data Available
What is Kintara Therapeutics’s market cap?
Currently, no data Available
When is Kintara Therapeutics’s upcoming earnings report date?
Kintara Therapeutics’s upcoming earnings report date is Nov 11, 2024 which is 11 days ago.
How were Kintara Therapeutics’s earnings last quarter?
Kintara Therapeutics released its earnings results on Oct 08, 2024. The company reported -$1.4 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.4.
Is Kintara Therapeutics overvalued?
According to Wall Street analysts Kintara Therapeutics’s price is currently Overvalued.
Does Kintara Therapeutics pay dividends?
Kintara Therapeutics does not currently pay dividends.
What is Kintara Therapeutics’s EPS estimate?
Kintara Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kintara Therapeutics have?
Currently, no data Available
What happened to Kintara Therapeutics’s price movement after its last earnings report?
Kintara Therapeutics reported an EPS of -$1.4 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.058%.
Which hedge fund is a major shareholder of Kintara Therapeutics?
Currently, no hedge funds are holding shares in KTRA
---
Kintara Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Positive
Last 7 Days ▲ 1.9%
Last 30 Days ▼ 0.3%
Last 30 Days ▼ 0.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-95.57%
12-Months-Change
Fundamentals
Return on Equity
-370.77%
Trailing 12-Months
Asset Growth
55.87%
Trailing 12-Months
Company Description
Kintara Therapeutics
DelMar Pharmaceuticals, Inc. is a clinical and biopharmaceutical company, which focuses on the development and commercialization of new cancer therapies. It pipeline includes the VAL-083. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.
---
KTRA Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---